Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients

Figure 2

Difference of IL-33 expression in gout patients with tophi, hypertension, and HDL. The renal function was affected by tophi, hyperlipoidemia, and hypertension in gout patients. The serum levels of IL-33 in patients were grouped according to tophi, hypertension, and HDL. These groups were evaluated by Mann-Whitney test.

(a)

(b)

(c)